Nasal Spray for Depression Gets New Approved Use
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.
Tick Season Means Lyme Disease
Lyme disease is a well-known risk tied to tick bites, so for those living in certain areas, a tick bite can be a nerve-racking experience. But there are ways to lower your risk.
FDA Expands List of Dangerous Hand Sanitizers
The US Food and Drug Administration (FDA) continues to find issues with certain hand sanitizer products.
Approved: New Kind of COVID-19 Test
The US Food and Drug Administration (FDA) has authorized two new COVID-19 tests.
Companies Under Fire for Illegal Hangover Products
The US Food and Drug Administration (FDA) has issued warning letters to seven companies that were selling illegal hangover products.
School's Out. Now What?
School is out and summer vacation is in full swing. Instead of letting your children plop down in front of the television for the next month, keep them engaged and active this summer.
New COVID-19 Test Gets Green Light
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a new COVID-19 diagnostic test that can test people who are not showing symptoms.
Naloxone and Opioid Overdose
The US Food and Drug Administration (FDA) has issued a drug safety communication for opioids and medications used to treat opioid use disorder.
Narcolepsy Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment option for narcolepsy.
We Answered Your Medication Questions
You asked and we answered. Find out the answers to three common questions pharmacists receive.